Over 20 Pennsylvania Auctions End Tomorrow 11/06 - Bid Now
Over 100 Total Lots Up For Auction at One Location - CA 11/08

Medline taps Microsoft for inventory management software

por Gus Iversen, Editor in Chief | October 22, 2024
Business Affairs
Medline Industries has partnered with Microsoft to enhance the resilience of healthcare supply chains through a new digital solution called Mpower.

The Northfield, Illinois-based medical supplier aims to tackle ongoing supply chain disruptions and operational inefficiencies within healthcare settings, leveraging Microsoft's technology to simplify inventory management and streamline decision-making.

The Mpower platform will be built on Microsoft 365 and incorporate Azure AI, including Microsoft Copilot, to provide predictive insights and actionable recommendations. These features are designed to help supply chain professionals anticipate and address inventory needs more effectively.

By integrating with existing systems, the platform seeks to avoid the time-consuming implementations often associated with new technology, reducing the burden on healthcare staff.

"Healthcare today is dealing with a crisis of complexity, and Medline exists to make healthcare run better," said Jim Boyle, Medline’s CEO, highlighting the collaboration as a means to "revolutionize the way we ensure a resilient healthcare supply chain."

The platform's predictive capabilities aim to free up resources, allowing providers to redirect more time and focus toward patient care.

Microsoft’s president of Americas, Deb Cupp, echoed Boyle's sentiment, pointing to the potential of AI-driven solutions to reduce administrative burdens. "Together with Medline, we're helping to address a unique piece of this puzzle — the healthcare supply chain," Cupp said.

Medline is a leading provider of medical-surgical products and healthcare solutions, operating in over 100 countries. In 2021, investment firms Blackstone, Carlyle, and Hellman & Friedman partnered together to fund a $34 billion majority investment in the company, making it one of the largest leveraged buyouts since the 2008 financial crisis.

Since then, Medline has announced many vendor partnerships and established facilities to enhance its supply chain efficiencies. Earlier this year, anonymous insiders said the company may be in the early stages of going public at a $50 billion valuation in 2025.

You Must Be Logged In To Post A Comment